Completed PHASE4 INTERVENTIONAL 2-arm NCT00221013

Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

Multicentre, Unblinded, Open Label, Randomised, Controlled Trial to Assess the Effect of Augmented Vs. Normal Continuous Renal Replacement Therapy (CRRT) on 90-Day All-Cause Mortality of Intensive Care Unit Patients With Severe Acute Renal Failure (ARF).

Sponsor: ANZICS Clinical Trials Group

Conditions Acute Renal Failure

Interventions augmented CRRT regimen

Updated 5 times since 2017 Last updated: Feb 25, 2009 Started: Nov 30, 2005 Primary completion: Oct 31, 2008 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Renal Failure and is currently completed. ANZICS Clinical Trials Group leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ANZICS Clinical Trials Group
The George Institute

Data source: The George Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Heidelberg, Australia